ICU Medical, Inc. (NASDAQ:ICUI) Stake Boosted by Vanguard Group Inc.

Vanguard Group Inc. increased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 14.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,440,729 shares of the medical instruments supplier’s stock after acquiring an additional 315,103 shares during the period. Vanguard Group Inc. owned about 10.11% of ICU Medical worth $243,438,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of ICUI. Charles Schwab Investment Management Inc. increased its position in ICU Medical by 14.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 192,773 shares of the medical instruments supplier’s stock worth $19,227,000 after purchasing an additional 23,816 shares during the last quarter. WCM Investment Management LLC raised its position in ICU Medical by 37.5% during the fourth quarter. WCM Investment Management LLC now owns 242,808 shares of the medical instruments supplier’s stock valued at $24,223,000 after acquiring an additional 66,221 shares in the last quarter. Principal Financial Group Inc. lifted its stake in ICU Medical by 37.8% in the fourth quarter. Principal Financial Group Inc. now owns 107,335 shares of the medical instruments supplier’s stock valued at $10,706,000 after acquiring an additional 29,464 shares during the last quarter. State of Alaska Department of Revenue grew its position in ICU Medical by 417.8% in the fourth quarter. State of Alaska Department of Revenue now owns 12,475 shares of the medical instruments supplier’s stock worth $1,244,000 after acquiring an additional 10,066 shares in the last quarter. Finally, Maryland State Retirement & Pension System acquired a new position in shares of ICU Medical during the 4th quarter worth $890,000. Institutional investors and hedge funds own 96.10% of the company’s stock.

Analyst Ratings Changes

ICUI has been the topic of several analyst reports. Needham & Company LLC began coverage on shares of ICU Medical in a research report on Friday, June 21st. They set a “hold” rating on the stock. Raymond James raised ICU Medical from a “market perform” rating to an “outperform” rating and set a $135.00 price objective on the stock in a report on Monday, June 17th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and a consensus price target of $127.00.

ICU Medical Stock Up 0.0 %

ICU Medical stock opened at $118.75 on Monday. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.61 and a quick ratio of 1.09. ICU Medical, Inc. has a fifty-two week low of $78.28 and a fifty-two week high of $182.62. The firm has a fifty day moving average price of $106.93 and a two-hundred day moving average price of $102.21. The firm has a market cap of $2.89 billion, a price-to-earnings ratio of -48.47 and a beta of 0.73.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.06. The firm had revenue of $566.66 million during the quarter, compared to the consensus estimate of $553.15 million. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. As a group, analysts forecast that ICU Medical, Inc. will post 3.5 earnings per share for the current year.

Insider Activity

In related news, COO Christian B. Voigtlander sold 12,539 shares of the business’s stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $103.95, for a total transaction of $1,303,429.05. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other ICU Medical news, Director Elisha W. Finney sold 300 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $104.95, for a total value of $31,485.00. Following the completion of the sale, the director now owns 2,129 shares in the company, valued at approximately $223,438.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Christian B. Voigtlander sold 12,539 shares of the business’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $103.95, for a total value of $1,303,429.05. The disclosure for this sale can be found here. Over the last three months, insiders sold 14,839 shares of company stock valued at $1,546,014. 6.70% of the stock is owned by company insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.